Oncology Round-Up: Demographic Differences in Cancer Survival; and More

The Journey of Roe Roe: A Brave Girl Battling Leukemia

Facing a family member’s cancer diagnosis is hard. Being the parents of a child diagnosed with cancer may be one of the hardest challenges on Earth. That is the challenge faced by Fox8 news anchor and Emmy-award winning journalist Chad Tucker and his wife, Meredith, following their daughter Peal Monroe “Roe Roe” Tucker having been diagnosed with acute lymphocytic leukemia (ALL) three years ago.

Demographic Differences in Lung, Prostate, Breast, and Colorectal Cancer Survival

“Researchers concluded that, “even after accounting for sociodemographic and tumor characteristics… non-Hispanic Black patients with cancer are particularly vulnerable to cancer burden, and resources are urgently needed to reverse decades-old survival trends.”

Insoo Park, CEO, Ecosense, Discusses Radon – The Leading Cause of Non-Smoker Lung Cancer

DocWire News recently spoke with Insoo Park, Founder and CEO of Ecosense, Inc. Mr. Park’s discussion focused on radon, the number one cause of non-smoker lung cancer.

Almost Half of Patients with High-risk Results Delay Follow-up Care for Lung Cancer

Research published in the ATS 2022 international conference found that 47 percent of patients at high risk for lung cancer after CT screening delayed follow-up care. As the leading cause of cancer deaths, lung cancer screening is done with low-dose chest CT to reduce mortality in high-risk patients. No previous study to date has evaluated follow-up delays for those with high-risk results, although many studies have examined poor follow-up rates for patients with negative baseline exams.

Immune-Related Long Non-Coding RNA Pairs in Laryngeal Squamous Cell Carcinoma

In BMC Cancer, researchers presented their experience in developing a predictive model based on seven immune-related long non-coding RNA pairs, which “demonstrated a better prognostic ability for LSCC patients and may assist clinicians to precisely prescribe chemo drugs.”

Geriatric Nutritional Risk Index to Predict Prognosis in Gastric Cancer

According to an article in BMC Cancer, the most accurate inflammation and nutritional biomarkers for predicting the prognosis of patients with gastric cancer is uncertain. The study’s lead author, Tomoyuki Matsunaga, and colleagues investigated various markers for their efficacy in predicting prognosis in patients over 75 years of age who were undergoing curative gastrectomy for gastric cancer. They concluded that the geriatric nutritional risk index (GNRI) “exhibited the best prognostic performance among several inflammation and nutritional markers in elderly patients with gastric cancer undergoing curative gastrectomy.”